Items Tagged ‘Allan Dietz’
April 11, 2022
Unleashing the body’s ability to heal
“We are the patient’s last, best hope,” has been the motto of the Immune, Progenitor and Cell Therapeutics lab, also known as the IMPACT lab, at Mayo Clinic. This lab specializes in clinical and investigative use of cells as living drugs within the body to fight disease and initiate healing when standard therapies don’t work. […]
Tags: Allan Dietz, CAR-T cell therapy, cellular therapy, Center for Regenerative Medicine, clinical trials, Dennis Gastineau, Franklyn Prendergast, mesenchymal stem cells, perianal fistula, Stanimar Vuk-Pavlovic
February 28, 2022
Preparing to deliver next-generation therapeutics
Mayo Clinic is among the academic medical centers on the cusp of biomanufacturing next-generation cell and gene therapies that offer hope of new cures for rare and complex diseases. Biomanufacturing this new era of biologic medicines is much different than manufacturing pharmaceuticals from complex molecules. It requires highly specialized lab infrastructure, new processes and new […]
Tags: Allan Dietz, biomedical engineering, CAR-T cell therapy, Center for Regenerative Medicine, clinical trials, Michael Gustafson, personalized medicine
February 15, 2022
Advancing a new era of regenerative medicine
Allegorically speaking, if Mayo Clinic were a garden and regenerative technologies were fruits and vegetables, William Faubion Jr., M.D., sees himself as a gardener tending to the teams responsible for these new healing therapies. Dr. Faubion, who is the newly named associate medical director for Mayo Clinic’s Center for Regenerative Medicine, wants to advance discoveries […]
Tags: Allan Dietz, biomedical engineering, CAR-T cell therapy, Center for Regenerative Medicine, Crohn's disease, Eric Dozois, gastroenterology, immune system, inflammatory bowel disease, perianal fistula, regenerative medicine research, surgery
November 17, 2020
Early-stage clinical trial provides hope for patients with traumatic spinal cord injuries
By Advancing the Science contributor 
Early research at Mayo Clinic is a step toward hope for a future treatment for patients with traumatic spinal cord injury. The research in this article discusses the experience related to the first case in a phase I safety study of mesenchymal stem cell treatment for spinal cord injury. The case study, found in Mayo Clinic […]
Tags: Allan Dietz, clinical trials, Mayo Clinic Proceedings, Mohamad Bydon, neurology, neurosurgery, regenerative medicine, spinal cord injury, Wenchun Qu
September 17, 2019
Mayo Clinic Startup Earns World Economic Forum Award
With the promise of potential lifesaving treatments like chimeric antigen receptor (CAR) T-Cell therapy comes complex challenges. For instance: how can we be sure the right cells are going to the right patient? How can we communicate problems with manufacturing that would affect a patient’s treatment schedule? To address those concerns, Mayo Clinic startup company […]
Tags: Allan Dietz, CAR-T cell therapy, Center for Regenerative Medicine, Jeffrey Winters, Mayo Clinic Ventures, Yi Lin
May 6, 2019
Mayo Clinic introduces new fellowship programs
By Advancing the Science contributor
Mayo Clinic’s Department of Laboratory Medicine and Pathology and the Division of Transfusion Medicine have launched two new graduate medical education fellowship programs — one in cellular therapy and one in clinical informatics. These programs are two of nearly 300 residencies and fellowships in Mayo Clinic School of Graduate Medical Education. Cellular therapy The Cellular […]
Tags: Allan Dietz, cellular therapy, clinical informatics, Eapen Jacob, Mayo Clinic School of Graduate Medical Education, research education, Taofic Mounajjed, Thomas Flotte